162 related articles for article (PubMed ID: 26091691)
1. The case for vaccine development in the strategy to eradicate river blindness (onchocerciasis) from Africa.
Makepeace BL; Babayan SA; Lustigman S; Taylor DW
Expert Rev Vaccines; 2015; 14(9):1163-5. PubMed ID: 26091691
[TBL] [Abstract][Full Text] [Related]
2. Elimination of onchocerciasis from Colombia: first proof of concept of river blindness elimination in the world.
Nicholls RS; Duque S; Olaya LA; López MC; Sánchez SB; Morales AL; Palma GI
Parasit Vectors; 2018 Apr; 11(1):237. PubMed ID: 29642939
[TBL] [Abstract][Full Text] [Related]
3. Onchocerca volvulus: The Road from Basic Biology to a Vaccine.
Lustigman S; Makepeace BL; Klei TR; Babayan SA; Hotez P; Abraham D; Bottazzi ME
Trends Parasitol; 2018 Jan; 34(1):64-79. PubMed ID: 28958602
[TBL] [Abstract][Full Text] [Related]
4. Reaching the last mile: main challenges relating to and recommendations to accelerate onchocerciasis elimination in Africa.
Gebrezgabiher G; Mekonnen Z; Yewhalaw D; Hailu A
Infect Dis Poverty; 2019 Jul; 8(1):60. PubMed ID: 31269966
[TBL] [Abstract][Full Text] [Related]
5. Advancing a Human Onchocerciasis Vaccine From Antigen Discovery to Efficacy Studies Against Natural Infection of Cattle With
Zhan B; Bottazzi ME; Hotez PJ; Lustigman S
Front Cell Infect Microbiol; 2022; 12():869039. PubMed ID: 35444961
[TBL] [Abstract][Full Text] [Related]
6. Elimination of transmission of onchocerciasis (river blindness) with long-term ivermectin mass drug administration with or without vector control in sub-Saharan Africa: a systematic review and meta-analysis.
Mutono N; Basáñez MG; James A; Stolk WA; Makori A; Kimani TN; Hollingsworth TD; Vasconcelos A; Dixon MA; de Vlas SJ; Thumbi SM
Lancet Glob Health; 2024 May; 12(5):e771-e782. PubMed ID: 38484745
[TBL] [Abstract][Full Text] [Related]
7. Doxycycline plus ivermectin versus ivermectin alone for treatment of patients with onchocerciasis.
Abegunde AT; Ahuja RM; Okafor NJ
Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD011146. PubMed ID: 26771164
[TBL] [Abstract][Full Text] [Related]
8. Onchocerciasis and other eye problems in developing countries: a challenge for optometrists.
Berger IB; Nnadozie J
J Am Optom Assoc; 1993 Oct; 64(10):699-702. PubMed ID: 8245390
[TBL] [Abstract][Full Text] [Related]
9. Elimination of onchocerciasis in Africa by 2025: the need for a broad perspective.
Cupp E; Sauerbrey M; Cama V; Eberhard M; Lammie PJ; Unnasch TR
Infect Dis Poverty; 2019 Jul; 8(1):50. PubMed ID: 31303176
[TBL] [Abstract][Full Text] [Related]
10. Onchocerca volvulus infection and serological prevalence, ocular onchocerciasis and parasite transmission in northern and central Togo after decades of Simulium damnosum s.l. vector control and mass drug administration of ivermectin.
Komlan K; Vossberg PS; Gantin RG; Solim T; Korbmacher F; Banla M; Padjoudoum K; Karabou P; Köhler C; Soboslay PT
PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006312. PubMed ID: 29494606
[TBL] [Abstract][Full Text] [Related]
11. Human Onchocerciasis: Modelling the Potential Long-term Consequences of a Vaccination Programme.
Turner HC; Walker M; Lustigman S; Taylor DW; Basáñez MG
PLoS Negl Trop Dis; 2015; 9(7):e0003938. PubMed ID: 26186715
[TBL] [Abstract][Full Text] [Related]
12. River Blindness: Mathematical Models for Control and Elimination.
Basáñez MG; Walker M; Turner HC; Coffeng LE; de Vlas SJ; Stolk WA
Adv Parasitol; 2016; 94():247-341. PubMed ID: 27756456
[TBL] [Abstract][Full Text] [Related]
13. Optimization and evaluation of the Esperanza Window Trap to reduce biting rates of Simulium damnosum sensu lato in Northern Uganda.
Loum D; Cozart D; Lakwo T; Habomugisha P; Jacob B; Cupp EW; Unnasch TR
PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007558. PubMed ID: 31310607
[TBL] [Abstract][Full Text] [Related]
14. Research for new drugs for elimination of onchocerciasis in Africa.
Kuesel AC
Int J Parasitol Drugs Drug Resist; 2016 Dec; 6(3):272-286. PubMed ID: 27693536
[TBL] [Abstract][Full Text] [Related]
15. Modelling the impact of ivermectin on River Blindness and its burden of morbidity and mortality in African Savannah: EpiOncho projections.
Turner HC; Walker M; Churcher TS; Basáñez MG
Parasit Vectors; 2014 May; 7():241. PubMed ID: 24886747
[TBL] [Abstract][Full Text] [Related]
16. From river blindness control to elimination: bridge over troubled water.
Colebunders R; Basáñez MG; Siling K; Post RJ; Rotsaert A; Mmbando B; Suykerbuyk P; Hopkins A
Infect Dis Poverty; 2018 Mar; 7(1):21. PubMed ID: 29587844
[TBL] [Abstract][Full Text] [Related]
17. Onchocerciasis (river blindness) - more than a century of research and control.
Brattig NW; Cheke RA; Garms R
Acta Trop; 2021 Jun; 218():105677. PubMed ID: 32857984
[TBL] [Abstract][Full Text] [Related]
18. Progress toward elimination of onchocerciasis in the Americas - 1993-2012.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2013 May; 62(20):405-8. PubMed ID: 23698606
[TBL] [Abstract][Full Text] [Related]
19. Hypo-endemic onchocerciasis hotspots: defining areas of high risk through micro-mapping and environmental delineation.
Kelly-Hope LA; Unnasch TR; Stanton MC; Molyneux DH
Infect Dis Poverty; 2015; 4():36. PubMed ID: 26279835
[TBL] [Abstract][Full Text] [Related]
20. Taking the strain out of onchocerciasis? A reanalysis of blindness and transmission data does not support the existence of a savannah blinding strain of onchocerciasis in West Africa.
Cheke RA; Little KE; Young S; Walker M; Basáñez MG
Adv Parasitol; 2021; 112():1-50. PubMed ID: 34024357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
